SCHEMBL18789767

SCHEMBL18789767

CC1COc2cc(NC(=O)c3cccc(C(=O)Nc4ccc5cccnc5c4)c3)ccc2N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ NPC1 O15118 5/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ TRPV1 Q8NER1 3/20 0.45
▸ PABPC1 P11940 1/20 0.44
▸ HSF1 Q00613 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ ROCK2 O75116 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PARP1 P09874 1/20 0.40
▸ CRHBP P24387 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22284873 0.81 CYP3A4 (0.58) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL18789761 0.80 MEN1 (0.50) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL25547918 0.77 KMT2A (0.67) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL7101847 0.72 PABPC1 (0.79) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL25687994 0.71 MEN1 (0.39) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL3878438 0.70 MEN1 (0.74) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL14073886 0.69 CYP3A4 (0.55) MEN1KMT2ANPC1RAB9ACASP3
Pyridine SCHEMBL29191407 0.68 PABPC1 (0.71) MEN1KMT2ANPC1RAB9ACASP3
SCHEMBL30597957 0.68 MEN1 (0.47) MEN1KMT2ANPC1TRPV1PABPC1
SCHEMBL4427327 0.68 MEN1 (0.73) MEN1KMT2ANPC1RAB9ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017070719-A2 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIVERSITY OF TECHNOLOGY (ZA) 2017-04-27 — — WO disclosed
WO-2017070718-A1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIVERSITY OF TECHNOLOGY (ZA) 2017-04-27 — — WO disclosed
Send feedback